Clinical Trials in Rochefort, France
3 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 3
AVAJAK: Apixaban/Rivaroxaban Versus Aspirin for Primary Prevention of Thrombo-embolic Complications in JAK2V617F-positive Myeloproliferative Neoplasms
Polycythemia VeraEssential ThrombocythemiaHigh Risk Patients+2 more
University Hospital, Brest1,308 enrolled42 locationsNCT05198960
Recruiting
Quality of Care in French HIV Infected Patients
HIV
DatAids30,000 enrolled39 locationsNCT02898987
Recruiting
Chronic Myeloid Leukemia (CML) Real-Life Database
Chronic Myeloid Leukemia (CML)
University Hospital, Clermont-Ferrand3,500 enrolled14 locationsNCT05963061